We recommend using a newer internet browser, such as Google Chrome or Microsoft Edge, to optimize your browsing experience.

Skip to main content

Safety and Effectiveness of Novantrone Therapy Followed by Copaxone

- Relapsing Remitting Multiple Sclerosis
- Completed

Study Title: A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone for Multiple Sclerosis.

Teva Identifier: NC-100

ClinicalTrials.gov Identifier: NCT00203073

Study Status: Completed

Trial Condition(s): Relapsing Remitting Multiple Sclerosis

Interventions: Drug: glatiramer acetate 20 mg | Drug: glatiramer acetate 20 mg, with mitoxantrone

Study Description: Please refer to ClinicalTrials.gov for a description of the trial

ClinicalTrials.gov study records with inclusion and exclusion criteria

neurology icon for clinical trials

Key Participation Requirements

Gender: Female, Male

Age Range: 18 Years to 55 Years

Trial Duration: 06/01/2003 - 04/01/2005

Phase: Phase 2

Study Type

Interventional